Delivery Order SPE2DB22D3016-SPE2DB25FBAZ5

Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,199.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 14, 2023 and was awarded on November 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRIUMEQ 600-50-300 MG TABLET. The contract has a ceiling value of $9,662.91 and a completion date of March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET in quantities of 30s, with a ceiling value of $6,519.84 and a completion date of June 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award, valued at $47,279.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a firm fixed-price delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through December 11, 2024. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,862.01 contract is for the supply of TRIUMEQ 600-50-300 MG TABLET prescription medication, with a completion date of November 29, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a $13,233.19 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency Troop Support Medical. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET with an ultimate completion date of May 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,039.74 firm fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET prescription medication. The contract has an ultimate completion date of January 3, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,794.40 firm fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET with an ultimate completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $8,885.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,080.28, is for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024 and is a firm fixed-price type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FBAZ5
    Delivery Order

This is a $6,519.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRIUMEQ 600-50-300 MG TABLET in quantities of 30. The contract has an ultimate completion date of July 7, 2025 and is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 10/2/25, 11:06 AM